Therapeutic Advancements for the Treatment of High-Risk MDS: Future Opportunities to Improve Patient Survival and Quality of Life
Are you up to date on MDS? Engage with a leading oncology expert on recent changes in MDS classification and risk assessment of risk. Learn about emerging therapies for high-risk MDS and how they may impact clinical practice through case discussions.
Do you have questions about the latest in MDS, such as:
- What are the classifications of MDS?
- What is the IPSS-M, and how do I use it to assess risk?
- How should I manage patients with high-risk MDS?
- What are the unmet needs for patients with high-risk MDS?
- Are there emerging therapies for high-risk MDS, and how do they work?
- Where might emerging therapies fit in the current treatment paradigm?
Join the discussion to get answers to these questions and more! Don’t get left behind and be ready to incorporate emerging therapies into your treatment plans for high-risk MDS.
Dates and times will be added on a rolling basis, click on the link below to participate.
Therapeutic Advancements for the Treatment of High-Risk MDS: Future Opportunities to Improve Patient Survival and Quality of Life
Live WebinarFaculty: Daniel Pollyea, MD, MS
Date: Tuesday, October 17, 2023 12:00 PM CDT
